MULTI-001 Nivolumab v7 MULTI-002 Carboplatin and etoposide v1 MULTI-003 Pembrolizumab v9 MULTI-010 ECX v2 MULTI-011 ECF v2 MULTI-012 ECarboX v2 MULTI-013 ECarboF v2 MULTI-018 Larotrectinib v2 MULTI-019 Entrectinib v1 MULTI-023 Selpercatinib v1
HNT-016 TPF v9 HNT-018 TP v3 HNT-025 Carboplatin, 5-Fluorouracil and Cetuximab v2 HNT-026 Cisplatin, 5-Fluorouracil and Cetuximab v1 HNT-027 T-Carbo v1 HNT-028 Cabozantinib v1 HNT-029 Lenvatinib (LENVIMA®) for thyroid cancer v1
